Novo Nordisk Pharmatech A/S
Pharmaceutical Manufacturing • 
Køge, Region Zealand, Denmark • 501-1000 Employees
Company overview
| Headquarters | Københavnsvej 216, Køge, 4600, DK |
| Phone number | +4513246149 |
| Website | |
| NAICS | 3254 |
| Keywords | BAC, Bak) Ph.Eur., Benzalkonium Chloride (Bkc, Recombinant Insulin Human Af, Usp/Nf, Trypsinnex |
| Founded | 1949 |
| Employees | 501-1000 |
| Socials |
Key Contact at Novo Nordisk Pharmatech A/S
Novo Nordisk Pharmatech A/S Email Formats
Novo Nordisk Pharmatech A/S uses 5 email formats. The most common is {first name} (e.g., john@novonordisk.com), used 69.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@novonordisk.com | 69.4% |
{2char} | {2char}@novonordisk.com | 13.9% |
{last name}{first initial} | doej@novonordisk.com | 8.3% |
{first initial}{last name} | jdoe@novonordisk.com | 5.6% |
About Novo Nordisk Pharmatech A/S
At Novo Nordisk Pharmatech, we are committed to developing life science solutions that enable medicines for our customers sustainably. We are proud that our innovative research and products help millions of people around the world live better lives. We are committed to making a difference with products that benefit people suffering from serious chronic diseases. We provide products to aid pharmaceutical manufacturing in four product areas: Recombinant Insu-lin, Enzymes, Benzalkonium Chloride, and Resins. We will continue strengthening our partnerships with those customers needing animal-free and reliable ingredients supplied securely and consistent-ly. Quality is our top priority, and we always ensure high batch-to-batch consistency across our prod-ucts according to regulations, with cGMP being a key capability. We have attracted an extensive roster of leading pharmaceutical companies through unsurpassed product quality, manufacturing and quality control, regulatory documentation, precision delivery and a comprehensive risk mitigation strategy. TrypsiNNex® TrypsiNNex® is an animal-free, recombinant porcine trypsin that delivers exceptional performance and consistency for highly regulated biopharma manufacturing processes. Launched in 2024. Recombinant Insulin Recombinant Insulin is used to produce monoclonal antibodies, virus vaccines, gene therapy drugs, and other innovative biologic products approved for use by regulatory bodies worldwide, including FDA and EMA. Benzalkonium Chloride (BKC) BKC is produced according to the highest cGMP standards and backed by complete regulatory doc-umentation. Our Benzalkonium Chloride products have proven efficacy against a broad spectrum of microorganisms through a wide pH range and are soluble in both oily and aqueous phases. We were established in 1949, acquired by Novo Nordisk in 1986 and have been part of the pharma-ceutical group since then.
Novo Nordisk Pharmatech A/S revenue & valuation
| Annual revenue | $53,700,000 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $171,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 501-1000
Seniority
Employees
Employees by Department
Novo Nordisk Pharmatech A/S has 278 employees across 17 departments.
Departments
Number of employees
Funding Data
Novo Nordisk Pharmatech A/S has never raised funding before.
Novo Nordisk Pharmatech A/S Tech Stack
Discover the technologies and tools that power Novo Nordisk Pharmatech A/S's digital infrastructure, from frameworks to analytics platforms.
Cookie compliance
WordPress plugins
JavaScript libraries
JavaScript libraries
WordPress themes
Page builders
JavaScript libraries
CDN
Marketing automation
Font scripts
JavaScript libraries
Miscellaneous
France
Brazil
Germany
Canada
Switzerland
Korea, Republic of
Sweden
Congo, The Democratic Republic of theFrequently asked questions
4.8
40,000 users
